Allarity reduces Series A preferred conversion price to $1.00, cuts warrant exercise price

Allarity Therapeutics, Inc.

Conversion price of Series A Preferred Stock amended from $4.50 to $1.00 per share.
Exercise price of existing warrants reduced to $1.00, matching the September 14 closing price.
New inducement warrants issued at $1.00 exercise price upon exercise of existing warrants.
Waiver from 3i, LP permits resale registration for shares underlying inducement warrants.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Allarity Therapeutics, Inc.: Fourth Certificate of Amendment to Amended and Restated Certificate of Designations of Series A Convertible Preferred Stock filed to reduce the conversion price from $4.50 to $1.00 (effective 2023-09-22).

Change: charter amendment
Effective: 2023-09-22

Exact text from the filing

On September 22, 2023 the Company filed the Fourth Certificate of Amendment to Amended and Restated Certificate of Designations of Series A Convertible Preferred Stock

View on SEC.gov

83 governance changes filed in the last 30 days. Browse all governance changes →

Allarity Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-079918

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.